MENU
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

Profile

Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
594
Web
https://www.crinetics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.01B
P/E Ratio
N/A
Total Cash
1.29B
Projected Growth
N/A
Total Debt
47.19M
Revenue
18.07M
Risk (Beta)
-0.67
Dividend Yield
N/A
Total Cash/Share
12.17
Total Debt/Equity
N/A
Revenue/Share
0.42 USD as % of share price
Who owns Crinetics Pharmaceuticals? CRNX symbol Ownership - Tickeron.com